Sirolimus utilization in pediatric liver transplantation: A large high‐volume quaternary center experience
Journal of Pediatric Gastroenterology and Nutrition · 2025
DOI: 10.1002/jpn3.70073 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Pediatric Gastroenterology and Nutrition, 2025. Verfasst von Wenly Ruan und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Baylor College of Medicine, Houston, Texas, USA. Hauptthemen laut MEDLINE: Liver Transplantation, Sirolimus, Immunosuppressive Agents, Graft Rejection. Die Arbeit nennt 26 Literaturangaben. Gefördert von: None.
Abstract (Originalsprache)
Objectives
Optimization of liver transplant (LT) immunosuppression is essential for long‐term graft function in children. Mammalian target of rapamycin (mTOR) inhibitors, such as sirolimus, have not been extensively studied in pediatric LT. We aimed to explore the usage of and indications for sirolimus at a quaternary pediatric LT center in a retrospective cohort analysis.
Methods
Pediatric LT patients who received sirolimus from 2010 to 2018 were included. Their electronic medical records were evaluated for demographic information, clinical data, and laboratory data before and after initiation of sirolimus.
Results
Sirolimus was initiated on 41 pediatric LT recipients at a median of 0.67 years post‐transplant (interquartile range [IQR]: 0.13–1.83) at Texas Children's Hospital. The leading indications for initiating sirolimus were chronic rejection (CR) ( n = 12, 29.3%), T‐cell‐mediated rejection (TCMR) on tacrolimus ( n = 8, 19.5%), posterior reversible encephalopathy syndrome (PRES) ( n = 8, 19.5%), and unresectable hepatic tumors/malignancies ( n = 7, 17.1%). Among patients started on sirolimus for CR, 58% ( n = 7/12) demonstrated histological or biochemical improvement. Among those started for TCMR augmentation, 62.5% experienced biochemical improvement. No patients who started on sirolimus for unresectable hepatic tumors/malignancies had malignancy recurrence 1‐year post‐LT. Median cholesterol and triglyceride levels 1‐year post‐initiation were higher than values 1‐year pre‐initiation ( p < 0.0001); however, sirolimus‐induced anemia, nephrotoxicity, and HAT were not observed.
Conclusions
This study is among the first to review the clinical experience of sirolimus usage in pediatric LT. Our experience suggests sirolimus can be used safely and effectively. Further research is warranted to evaluate long‐term benefits, adverse effects, and optimal dosing of sirolimus in pediatric liver transplantation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pediatrics, Baylor College of Medicine, Houston, Texas, USA.
- Section of Pediatric Gastroenterology, Hepatology, and Nutrition, Texas Children's Hospital, Houston, Texas, USA.
- Department of Pharmacy, Texas Children's Hospital, Houston, Texas, USA.
- Department of Pediatric Surgery, Texas Children's Hospital, Houston, Texas, USA.
- Division of Abdominal Transplantation, Michael E. DeBakey Department of Surgery, Baylor College of Medicine, Houston, Texas, USA.
ORCID-Profile: Wenly Ruan
Förderung
- None
Zitieren
APA
Ruan, W., Cerminara, D. N., Galvan, N. T. N., Fishman, D. S., Harpavat, S., Hertel, P. M., Mysore, K. R., Tessier, M. E., Fuller, K., Faraone, M., Cotton, R. T., O'Mahony, C. A., Rana, A., Goss, J. A., & Leung, D. H. (2025). Sirolimus utilization in pediatric liver transplantation: A large high‐volume quaternary center experience. Journal of Pediatric Gastroenterology and Nutrition. https://doi.org/10.1002/jpn3.70073
Vancouver
Ruan W, Cerminara DN, Galvan NTN, Fishman DS, Harpavat S, Hertel PM, et al. Sirolimus utilization in pediatric liver transplantation: A large high‐volume quaternary center experience. Journal of Pediatric Gastroenterology and Nutrition. 2025. doi:10.1002/jpn3.70073
BibTeX
@article{Ruan2025,
author = {Ruan, Wenly and Cerminara, Dana N and Galvan, Nhu Thao Nguyen and Fishman, Douglas S and Harpavat, Sanjiv and Hertel, Paula M and Mysore, Krupa R and Tessier, Mary Elizabeth and Fuller, Kelby and Faraone, Marielle and Cotton, Ronald T and O'Mahony, Christine A and Rana, Abbas and Goss, John A and Leung, Daniel H},
title = {Sirolimus utilization in pediatric liver transplantation: A large high‐volume quaternary center experience},
journal = {Journal of Pediatric Gastroenterology and Nutrition},
year = {2025},
doi = {10.1002/jpn3.70073}
}
EUVIMED